Regio- and stereo-selective biotransformation of 2α,5α,10β,14β-tetra-acetoxy-4(20), 11-taxadiene by Ginkgo cell suspension cultures

被引:24
作者
Dai, JG
Ye, M
Guo, HZ
Zhu, WH
Zhang, DO
Hu, Q
Zheng, JH
Guo, D
机构
[1] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100083, Peoples R China
[2] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China
[3] Peking Union Med Coll, Beijing 100050, Peoples R China
基金
美国国家科学基金会;
关键词
taxane; sinenxan A; biotransformation; enzymes; cell suspension cultures; Ginkgo biloba;
D O I
10.1016/S0040-4020(02)00529-X
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Ginkgo biloba cell suspension cultures were used to bioconvert sinenxan A, 2alpha,5alpha, 10beta, 14beta-tetra-acetoxy-4(20), 11-taxadiene, a taxoid isolated from callus tissue cultures of Taxus spp. Besides two major products, 9alpha-hydroxy-2alpha,5alpha,10beta,14beta-tetra-acetoxy-4(20), 11-taxadiene 1 and 9alpha,10beta-dihydroxy-2alpha,5alpha,14beta-triacetoxy-4(20), 11-taxadiene 2, additional six minor products were obtained and five of them identified as new compounds. On the basis of chemical and spectral data, their structures were identified as 9alpha,14beta-dihydroxy-2alpha,5alpha,10beta-triacetoxy-4(20), 11-taxadiene 3, 6alpha,10beta-dihydroxy-2alpha,5alpha,14beta-triacetoxy-4(20), 11-taxadiene 4, 6alpha,9alpha,10beta-trihydroxy-2alpha,5alpha,14beta-triacetoxy-4(20), 11-taxadiene 5, 9alpha,10beta-O-(propane-2,2-diyl)-2alpha,5alpha,14beta-triacetoxy-4(20), 11-taxadiene 6, 9alpha-hydroxy-2alpha,5alpha,10beta,14beta-tetra-acetoxy-4(20), 11-taxadiene formate 7, 10beta-hydroxy-2alpha,5alpha,9alpha,14beta-tetra-acetoxy-4(20), 11-taxadiene formate 8, respectively. Investigation of the properties of the enzymes responsible for the biocatalysis process of sinenxan A to I and 2 revealed that the enzymes were extracellular and constitutive. Using sinenxan A and the two major products (1 and 2) as indicators, the stage and concentration of sinenxan A added and the kinetics of the biotransformation reaction were investigated. The results showed that: (1) the optimal stage for sinenxan A addition was the logarithmic phase of the cell growth period, in which sinenxan A was almost completely bioconverted, and the biotransformation rates were up to 60 and 20% for 1 and 2, respectively; (2) the optimal concentration of sinenxan A added was 60 mg/L; (3) the substrate was mainly converted into 1 and 2 in the first 48 h after addition and then into the minor products. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:5659 / 5668
页数:10
相关论文
共 37 条
[1]  
BOSCH I, 1996, BIOCHIM BIOPHYS ACTA, V1288, P37
[2]  
CHENG K, 1992, Patent No. 92249047
[3]  
CHENG KD, 1994, Patent No. 9406740
[4]   Synthesis and biological evaluation of novel 9-functional heterocyclic coupled 7-deoxy-9-dihydropaclitaxel analogue [J].
Cheng, Q ;
Oritani, T ;
Horiguchi, T ;
Yamada, T ;
Mong, Y .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (05) :517-521
[5]  
DAI J, 2000, ACTA PHARM SIN, V2, P151
[6]   Biotransformation of 2α,5α,10β,14β-tetra-acetoxy-4(20), 11-taxadiene by Ginkgo cell suspension cultures [J].
Dai, JG ;
Guo, HZ ;
Lu, DD ;
Zhu, WH ;
Zhang, DY ;
Zheng, JH ;
Guo, D .
TETRAHEDRON LETTERS, 2001, 42 (28) :4677-4679
[7]  
Floss H. G., 1995, TAXOL: Science and Applications, P191
[8]  
FORD JM, 1990, PHARMACOL REV, V42, P155
[9]  
GEORG GI, 1995, TAXOL SCI APPL, P317
[10]   BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].
GOTTESMAN, MM ;
PASTAN, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427